What is LGVN stock price today?

LGVN (Longeveron Inc) stock is trading at $1.10 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is LGVN stock going up or down today?

LGVN stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy LGVN stock now?

The decision to buy LGVN depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is LGVN a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for LGVN based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is LGVN stock overvalued or undervalued?

Use our DCF valuation calculator to determine if LGVN is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is LGVN's P/E ratio?

P/E ratio data for LGVN will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is LGVN's market cap?

LGVN (Longeveron Inc) has a market capitalization of $0.03 billion, making it a small-cap stock.

What is LGVN's price to book ratio?

LGVN trades at a price-to-book (P/B) ratio of 5.73, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does LGVN pay dividends?

LGVN does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is LGVN's dividend yield?

LGVN does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is LGVN stock a good long-term investment?

LGVN's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is LGVN's revenue growth rate?

LGVN has shown revenue growth of -0.4% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for LGVN are available on our dashboard with complete income statement analysis.

What are the risks of investing in LGVN?

Key risks for LGVN include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does LGVN compare to its competitors?

Compare LGVN to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize LGVN's performance and positioning.

What is LGVN's stock price target for 2026?

Our AI model provides price targets for LGVN based on fundamental analysis: Bull case $1.43 (+30%), Base case $1.27 (+15%), Bear case $0.99 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about LGVN?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for LGVN. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is LGVN's next earnings report?

LGVN reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

LGVN - Longeveron Inc

NYSE * Health Care * Biotechnology

$1.10

$-0.02 (-1.78%)

About Longeveron Inc

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.

LGVN Key Statistics

Market Cap

$32.79M

P/B Ratio

5.73

EPS

$-1.29

Revenue Growth

-0.4%

Employees

How LGVN Compares to Peers

LGVN is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
LGVN(This stock)	$32.79M	N/A	-0%	0.0%	-
AMGNAmgen Inc	$188.34B	24.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$171.97B	20.4	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$110.81B	28.4	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$78.87B	18.0	0%	0.3%	vs REGN
BIIBBiogen Inc	$26.03B	20.0	-0%	0.1%	vs BIIB

Longeveron Inc Company Information

Headquarters: Florida; U.S.A
Website: longeveron.com
Sector: Health Care
Industry: Biotechnology

Data Updated: April 18, 2026 at 2:54 PM EDT

Ready to invest in LGVN?

Commission-free trading available. Affiliate links.

LGVN Lician Score

10% confidence

4.0/10

Neutral

LGVN has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates LGVNacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

LGVN Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for LGVN

Dashboard

Enter a ticker to analyze